Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Neurology and Therapy
|
October 19, 2023
Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population
Lisa Belter, Ilse Peterson, Jill Jarecki
Contemporary Clinical Trials Communications
|
February 9, 2026
An updated review of the SMA clinical trial landscape in the United States: Findings from analysis of recruitment targets on ClinicalTrials.gov and a survey of SMA clinical trial sites on factors affecting site capacity and readiness
Fatou Sarr, Ilse Peterson, Jacqueline Glascock, et al.
JAMA Network Open
|
April 1, 2025
Accuracy of Medicare Information Provided by State Health Insurance Assistance Programs
Kacey Dugan, Ilse Peterson, Allison Dorneo, et al.
Immunobiology
|
February 24, 2018
T cell deficiencies as a common risk factor for drug associated progressive multifocal leukoencephalopathy
Dejan Pavlovic, Mayur A Patel, Andriani C Patera, et al.
Orphanet Journal of Rare Diseases
|
May 24, 2020
The SMA Clinical Trial Readiness Program: creation and evaluation of a program to enhance SMA trial readiness in the United States
Ilse Peterson, Rosángel Cruz, Fatou Sarr, et al.
Neurology and Therapy
|
June 22, 2023
Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights
Mary Curry, Ilse Peterson, Lisa Belter, et al.
Physical Therapy
|
July 29, 2022
Clinical and Research Readiness for Spinal Muscular Atrophy: The Time Is Now for Knowledge Translation
Kristin J Krosschell, Sally Dunaway Young, Ilse Peterson, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
March 15, 2012
Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop report
Carole Evans, David Cipolla, Tim Chesworth, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Neurology and Therapy
|
October 19, 2023
Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population
Lisa Belter, Ilse Peterson, Jill Jarecki
Contemporary Clinical Trials Communications
|
February 9, 2026
An updated review of the SMA clinical trial landscape in the United States: Findings from analysis of recruitment targets on ClinicalTrials.gov and a survey of SMA clinical trial sites on factors affecting site capacity and readiness
Fatou Sarr, Ilse Peterson, Jacqueline Glascock, et al.
JAMA Network Open
|
April 1, 2025
Accuracy of Medicare Information Provided by State Health Insurance Assistance Programs
Kacey Dugan, Ilse Peterson, Allison Dorneo, et al.
Immunobiology
|
February 24, 2018
T cell deficiencies as a common risk factor for drug associated progressive multifocal leukoencephalopathy
Dejan Pavlovic, Mayur A Patel, Andriani C Patera, et al.
Orphanet Journal of Rare Diseases
|
May 24, 2020
The SMA Clinical Trial Readiness Program: creation and evaluation of a program to enhance SMA trial readiness in the United States
Ilse Peterson, Rosángel Cruz, Fatou Sarr, et al.
Neurology and Therapy
|
June 22, 2023
Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights
Mary Curry, Ilse Peterson, Lisa Belter, et al.
Physical Therapy
|
July 29, 2022
Clinical and Research Readiness for Spinal Muscular Atrophy: The Time Is Now for Knowledge Translation
Kristin J Krosschell, Sally Dunaway Young, Ilse Peterson, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
March 15, 2012
Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop report
Carole Evans, David Cipolla, Tim Chesworth, et al.
Page
of 1